​

Funding Round

Series A - iVexSol

Series A - iVexSol

Investment Firm

Overview

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Announced Date

Jan 26, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorCasdin Capital
Participant InvestorAsahi Kasei Medical Europe
Participant InvestorBioLife Solutions
Participant InvestorCharles River Laboratories International
Participant InvestorBristol-Myers Squibb

Round Details and Background

iVexSol raised $23800000 on 2023-01-26 in Series A

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 26, 2019
Debt Financing - iVexSol
2-2.0M
Dec 01, 2020
Series A - iVexSol
2-13.0M
Aug 25, 2020
Convertible Note - iVexSol
1-250.0K
Jan 26, 2023
Series A - iVexSol
5-23.8M

Recent Activity

There is no recent news or activity for this profile.